Angiotensin-Converting Enzyme Inhibitors for Bevacizumab-Induced Hypertension
- 1 December 2006
- journal article
- letter
- Published by SAGE Publications in Annals of Pharmacotherapy
- Vol. 40 (12) , 2278-2279
- https://doi.org/10.1345/aph.1h244
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Blockade of VEGF accelerates proteinuria, via decrease in nephrin expression in rat crescentic glomerulonephritisKidney International, 2006
- Managing Patients Treated with Bevacizumab Combination TherapyOncology, 2005
- Targeted Therapy of Colorectal Cancer: Clinical Experience with BevacizumabThe Oncologist, 2004
- The VIVA TrialCirculation, 2003
- Angiotensin-Converting Enzyme Inhibitor Prevents Plasminogen Activator Inhibitor-1 Expression in a Rat Model with Cardiovascular Remodeling Induced by Chronic Inhibition of Nitric Oxide SynthesisJournal of Molecular and Cellular Cardiology, 2000